Developing a Cost-Effective Analysis of Anastrozole and Megestrol Acetate for the Palliative Treatment of Breast Cancer

doi 10.24124/1998/bpgub65
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

University of Northern British Columbia

Related search

Cost-Effectiveness of Anastrozole, in Comparison With Tamoxifen, in the Adjuvant Treatment of Early Breast Cancer in Brazil

Revista da Associacao Medica Brasileira
Medicine
2009English

Enhanced Antitumor Activity of Combined Megestrol Acetate and Arsenic Trioxide Treatment in Liver Cancer Cells

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Megestrol Acetate–Induced Adrenal Insufficiency

Cancer Control
MedicineOncologyHematology
2016English

Is Mass Screening for Breast Cancer Cost-Effective?

European Journal of Cancer
Cancer ResearchOncology
1996English

Anastrozole May Aid Breast Cancer Prevention

Cancer Discovery
Oncology
2013English

Pcn171 - A Cost-Utility Analysis of Fulvestrant Versus Anastrozole as First-Line Therapy for Oestrogen Receptor-Positive Locally Advanced and Metastatic Breast Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

A Cost-Effectiveness Analysis of Palbociclib and Other Aromatase Inhibitors for Treatment of Advanced Breast Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Effects of Megestrol Acetate on Adrenal Function and Survival in Cancer Patients

Endocrine Abstracts
2015English

A Comparison of Letrozole and Anastrozole Followed by Letrozole in Breast Cancer Patients

Breast Cancer: Targets and Therapy
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy